相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP
Yesim Parman et al.
CURRENT OPINION IN NEUROLOGY (2016)
Hereditary ATTR amyloidosis: a single-institution experience with 266 patients
Paul L. Swiecicki et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2015)
Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis
Yoshiki Sekijima et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2015)
Evolving landscape in the management of transthyretin amyloidosis
Philip N. Hawkins et al.
ANNALS OF MEDICINE (2015)
Genotype-Phenotype Correlation and Course of Transthyretin Familial Amyloid Polyneuropathies in France
Louise-Laure Mariani et al.
ANNALS OF NEUROLOGY (2015)
The Val30Met familial amyloid polyneuropathy specific Rasch-built overall disability scale (FAP-RODS(C))
Marielle H. J. Pruppers et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2015)
Rapid progression of familial amyloidotic polyneuropathy A multinational natural history study
David Adams et al.
NEUROLOGY (2015)
Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component
Duncan B. Richards et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Characterization of conformation-specific, human-derived monoclonal antibodies against TTR aggregates with potential for diagnostic and therapeutic use
Aubin Michalon et al.
Orphanet Journal of Rare Diseases (2015)
Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
Ole B. Suhr et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
Bo-Goran Ericzon et al.
TRANSPLANTATION (2015)
Impact of liver transplantation on the natural history of oculopathy in Portuguese patients with transthyretin (V30M) amyloidosis
Joao Melo Beirao et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2015)
In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography
Jennifer Kollmer et al.
BRAIN (2015)
Frequencies and geographic distributions of genetic mutations in transthyretin- and non-transthyretin-related familial amyloidosis
D. B. Zhen et al.
CLINICAL GENETICS (2015)
CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings
Luis F. Maia et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Transthyretin Induces Insulin-like Growth Factor I Nuclear Translocation Regulating Its Levels in the Hippocampus
Marta Vieira et al.
MOLECULAR NEUROBIOLOGY (2015)
Prediction of Long-Term Survival After Liver Transplantation for Familial Transthyretin Amyloidosis
Vincent Algalarrondo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
FAP Neuropathy and Emerging Treatments
David Adams et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2014)
Online Registry for Mutations in Hereditary Amyloidosis Including Nomenclature Recommendations
Dorota M. Rowczenio et al.
HUMAN MUTATION (2014)
Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trials
N. Suanprasert et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
An amyotrophic lateral sclerosis-like syndrome revealing an amyloid polyneuropathy associated with a novel transthyretin mutation
Pierre Lozeron et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2013)
Reduced Myocardial 123-Iodine Metaiodobenzylguanidine Uptake A Prognostic Marker in Familial Amyloid Polyneuropathy
Maria C. Azevedo Coutinho et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2013)
Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy
P. Lozeron et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Repurposing Diflunisal for Familial Amyloid Polyneuropathy A Randomized Clinical Trial
John L. Berk et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
Teresa Coelho et al.
JOURNAL OF NEUROLOGY (2013)
Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy
Maike F. Dohrn et al.
JOURNAL OF NEUROLOGY (2013)
TTR-related amyloid neuropathy: clinical, electrophysiological and pathological findings in 15 unrelated patients
Marco Luigetti et al.
NEUROLOGICAL SCIENCES (2013)
Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
Teresa Coelho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Effects of Tafamidis on Transthyretin Stabilization and Clinical Outcomes in Patients with Non-Val30Met Transthyretin Amyloidosis
Giampaolo Merlini et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2013)
Regional difference and similarity of familial amyloidosis with polyneuropathy in France
David Adams et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2012)
Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy
Elizabeth J. Ackermann et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2012)
Amyloid neuropathies
David Adams et al.
CURRENT OPINION IN NEUROLOGY (2012)
Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant
Prayman T. Sattianayagam et al.
EUROPEAN HEART JOURNAL (2012)
The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug
Steven M. Johnson et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas
Haruki Koike et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Tafamidis for transthyretin familial amyloid polyneuropathy A randomized, controlled trial
Teresa Coelho et al.
NEUROLOGY (2012)
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade
Christine E. Bulawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Clinical and histopathological features of familial amyloidotic polyneuropathy with transthyretin Val30Ala in a Chinese family
Jing-Yao Liu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
Karl Bodin et al.
NATURE (2010)
Clinical presentations and skin denervation in amyloid neuropathy due to transthyretin Ala97Ser
N. C-C. Yang et al.
NEUROLOGY (2010)
Progression of transthyretin amyloid neuropathy after liver transplantation
Juris J. Liepnieks et al.
NEUROLOGY (2010)
Transthyretin-related familial amyloidotic polyneuropathy -Progress in Kumamoto, Japan (1967-2010)-
Shukuro Araki et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2010)
Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus
Yako Kato-Motozaki et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides
MD Benson et al.
MUSCLE & NERVE (2006)
Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants
SR Miller et al.
LABORATORY INVESTIGATION (2004)
Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan - Early-vs late-onset form
H Koike et al.
ARCHIVES OF NEUROLOGY (2002)
The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation
D Adams et al.
BRAIN (2000)
分享论文
